- Home
- AQB vs GCTK Comparison
AQB vs GCTK Comparison
Compare AQB & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQB
- GCTK
- Stock Information
- Founded
- AQB 1991
- GCTK 2001
- Country
- AQB United States
- GCTK United States
- Employees
- AQB N/A
- GCTK N/A
- Industry
- AQB
- GCTK Medical/Dental Instruments
- Sector
- AQB
- GCTK Health Care
- Exchange
- AQB Nasdaq
- GCTK Nasdaq
- Market Cap
- AQB 2.9M
- GCTK 3.3M
- IPO Year
- AQB N/A
- GCTK N/A
- Fundamental
- Price
- AQB $1.18
- GCTK $4.26
- Analyst Decision
- AQB
- GCTK
- Analyst Count
- AQB 0
- GCTK 0
- Target Price
- AQB N/A
- GCTK N/A
- AVG Volume (30 Days)
- AQB 6.1M
- GCTK 36.1K
- Earning Date
- AQB 08-05-2025
- GCTK 08-14-2025
- Dividend Yield
- AQB N/A
- GCTK N/A
- EPS Growth
- AQB N/A
- GCTK N/A
- EPS
- AQB N/A
- GCTK N/A
- Revenue
- AQB N/A
- GCTK N/A
- Revenue This Year
- AQB N/A
- GCTK N/A
- Revenue Next Year
- AQB N/A
- GCTK N/A
- P/E Ratio
- AQB N/A
- GCTK N/A
- Revenue Growth
- AQB N/A
- GCTK N/A
- 52 Week Low
- AQB $0.47
- GCTK $4.22
- 52 Week High
- AQB $1.62
- GCTK $3,756.00
- Technical
- Relative Strength Index (RSI)
- AQB 78.76
- GCTK 31.52
- Support Level
- AQB $0.74
- GCTK $4.22
- Resistance Level
- AQB $1.60
- GCTK $5.64
- Average True Range (ATR)
- AQB 0.09
- GCTK 0.35
- MACD
- AQB 0.05
- GCTK -0.12
- Stochastic Oscillator
- AQB 53.33
- GCTK 8.43
About AQB AquaBounty Technologies Inc.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.